ZMYM2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.54419810272088E-11 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
5.62719999486205E-08 |
Normal-vs-Stage2 |
7.81579999999948E-05 |
Normal-vs-Stage3 |
1.9803999551371E-09 |
Normal-vs-Stage4 |
6.10649975030242E-10 |
Stage1-vs-Stage2 |
7.722800E-01 |
Stage1-vs-Stage3 |
4.512200E-02 |
Stage1-vs-Stage4 |
1.270250E-02 |
Stage2-vs-Stage3 |
3.444600E-01 |
Stage2-vs-Stage4 |
1.778030E-01 |
Stage3-vs-Stage4 |
5.296600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.51909596013411E-11 |
Normal-vs-AfricanAmerican |
2.25309999999368E-05 |
Normal-vs-Asian |
3.416600E-01 |
Caucasian-vs-AfricanAmerican |
7.280000E-01 |
Caucasian-vs-Asian |
1.691990E-01 |
AfricanAmerican-vs-Asian |
2.453200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.16039963696346E-10 |
Normal-vs-Female |
9.80060033128893E-10 |
Male-vs-Female |
7.864800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.249650E-04 |
Normal-vs-Age(41-60Yrs) |
2.07130000040578E-07 |
Normal-vs-Age(61-80Yrs) |
5.60373969449302E-12 |
Normal-vs-Age(81-100Yrs) |
1.82086999999109E-05 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.869600E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.262800E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.306200E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.827600E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.128100E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.035600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
2.860800E-01 |
Normal-vs-Grade 2 |
9.39109999986698E-07 |
Normal-vs-Grade 3 |
1.24059995609827E-09 |
Normal-vs-Grade 4 |
1.64820046499869E-10 |
Grade 1-vs-Grade 2 |
1.979970E-01 |
Grade 1-vs-Grade 3 |
1.286190E-02 |
Grade 1-vs-Grade 4 |
2.939900E-03 |
Grade 2-vs-Grade 3 |
2.508100E-02 |
Grade 2-vs-Grade 4 |
2.158200E-03 |
Grade 3-vs-Grade 4 |
1.518640E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.33690000003739E-06 |
Normal-vs-ccB subtype |
1.92930005304959E-09 |
ccA subtype-vs-ccB subtype |
4.040400E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.95290003560211E-09 |
Normal-vs-N1 |
2.814400E-04 |
N0-vs-N1 |
2.634600E-01 |
|
|